Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder

Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder

Abstract Background Buprenorphine-naloxone is an evidence-based treatment for Opioid Use Disorder. However, despite its efficacy, nearly half of participants are unsuccessful in achieving stabilization (i.e., period of time following medication induction in which medication dose is adjusted to be ef...

Full description

Bibliographic Details
Main Authors: Kirsten J. Langdon, Susan Ramsey, Caroline Scherzer, Kate Carey, Megan L. Ranney, Josiah Rich
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Addiction Science & Clinical Practice
Subjects:
Opioid use disorder
Buprenorphine
Medications for opioid use disorder
Distress tolerance
Motivational enhancement
Mobile treatment
Online Access:http://link.springer.com/article/10.1186/s13722-020-00189-4

Internet

http://link.springer.com/article/10.1186/s13722-020-00189-4

Similar Items